Skip to main content
letter
. 2022 Apr 29;37(14):3758–3761. doi: 10.1007/s11606-022-07633-y

Figure 1.

Figure 1

Trends in the proportion of buprenorphine inductions conducted via telemedicine among Medicare fee-for-service beneficiaries (January 2020 through May 2021). The denominator is the total number of buprenorphine inductions in a given month. Numerator is the number of buprenorphine inductions delivered via telemedicine. During the COVID-19 pandemic (March 13, 2020, through May 2021), we identified 22,569 inductions, 3,212 (14.7%) of which occurred via telemedicine.